Fig. 2.
The cumulative incidence of clinical chronic GVHD among the 23 bone marrow (BM) and the 23 PBSC recipients surviving without relapse beyond day 80. The tick marks and the horizontal axis scale are as in Fig 1.
The cumulative incidence of clinical chronic GVHD among the 23 bone marrow (BM) and the 23 PBSC recipients surviving without relapse beyond day 80. The tick marks and the horizontal axis scale are as in Fig 1.
